Why the study?
What is the rate of clinical plaque progression requiring nontarget lesion PCI in patients with incidental asymptomatic lesions discovered during culprit vessel PCI?
Population
PCI patients with incidental, asymptomatic lesions discovered during culprit vessel coronary intervention
Design
Cohort
Follow-up
1 year
Authors
Loading...
May support risk stratification by CAD burden post-PCI; leaves open whether targeted therapies reduce progression.
What is the rate of clinical plaque progression requiring nontarget lesion PCI in patients with incidental asymptomatic lesions discovered during culprit vessel PCI?
Approximately 6% of patients undergoing PCI experience clinical progression of incidental asymptomatic lesions requiring intervention within 1 year, with risk driven by greater baseline CAD burden.
Glaser et al. (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: